Joseph Catanzaro, PhD

Sr. Research Analyst
Sector Expertise
Additional Expertise
Joe Catanzaro is a director and senior research analyst at Piper Sandler covering biotechnology. Prior to joining Piper Sandler in 2018, Catanzaro spent four years at Cowen, where he also covered biotechnology. Before making the move to Wall Street, Catanzaro worked as a research scientist at Stony Brook University in New York. His work there focused on oncogene-mediated inflammatory signaling and resulted in multiple peer-reviewed publications. Catanzaro received his bachelor’s degree from Binghamton University in biological sciences and earned his Ph.D. in genetics from Stony Brook University.

Universe Coverage

CTMXCytomX Therapeutics, Inc.
CPRXCatalyst Pharmaceuticals, Inc.
CRDFCardiff Oncology, Inc.
RPTXRepare Therapeutics Inc.
HALOHalozyme Therapeutics, Inc.
IOVAIovance Biotherapeutics, Inc.
SGENSeagen, Inc.
KROSKeros Therapeutics, Inc.
IMGNImmunoGen, Inc.
OCULOcular Therapeutix, Inc.
EPIXESSA Pharma, Inc.
ACHLAchilles Therapeutics, Inc.
GRCLGracell Biotechnologies Inc.
NRIXNurix Therapeutics, Inc.
BMEABiomea Fusion, Inc.
LPTXLeap Therapeutics, Inc.
DAWNDay One Biopharmaceuticals, Inc.
AADIAadi Bioscience, Inc.
IBRXImmunityBio, Inc.
ACRVAcrivon Therapeutics, Inc.
RAINRain Oncology, Inc.
GILDGilead Sciences, Inc.
SDGRSchrodinger, Inc.
EXELExelixis, Inc.
BDTXBlack Diamond Therapeutics, Inc.
MRTXMirati Therapeutics, Inc.
TSBXTurnstone Biologics Corp.